Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
May 16 2017 - 8:43AM
Edgar (US Regulatory)
|
UNITED STATES
|
OMB APPROVAL
|
|
SECURITIES AND EXCHANGE COMMISSION
|
OMB Number: 3235-0058
|
|
Washington, D.C. 20549
|
Expires: August
31, 2015
|
|
|
|
|
|
Estimated
average burden
|
|
|
|
|
|
Hours
per response... 2.50
|
|
FORM 12b-25
|
|
|
|
SEC FILE NUMBER
|
|
|
|
|
|
|
|
|
CUSIP NUMBER
|
|
NOTIFICATION
OF LATE FILING
|
|
(Check
one):
[ ] Form 10-K [ ] Form 20F [ ]
Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR
For
Period Ended: March 31, 2017
[ ]
Transition Report on Form 10-K
[ ]
Transition Report on Form 20-F
[ ]
Transition Report on Form 11-K
[ ]
Transition Report on Form 10-Q
[ ]
Transition Report on Form N-SAR
For
the Transition Period Ended:
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
|
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART
I — REGISTRANT INFORMATION
Pressure
BioSciences Inc.
Full
Name of Registrant
Former
Name if Applicable
14
Norfolk Avenue
Address
of Principal Executive Office
(Street and Number)
South
Easton, MA 02375
City,
State and Zip Code
PART
II — RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if appropriate)
|
(a)
|
The
reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
|
|
|
|
[X]
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR,
or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject
quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be
filed on or before the fifth calendar day following the prescribed due date; and
|
|
|
|
|
(c)
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART
III – NARRATIVE
State
below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion
thereof, could not be filed within the prescribed time period.
(Attach
extra Sheets if Needed)
The
Registrant is unable to timely file its report on Form 10-Q for the quarter ended March 31, 2017 due to an unanticipated
delay in connection with the Securities and Exchange Commission. The Registrant expects to file within the extension
period.
|
PART
IV — OTHER INFORMATION
(1)
|
Name
and telephone number of person to contact in regard to this notification
|
|
Richard
T. Schumacher
|
|
508
|
|
230-1828
|
|
(Name)
|
|
(Area
Code)
|
|
(Telephone
Number)
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required
to file such report(s) been filed? If answer is no, identify report(s).
|
|
|
|
Yes [X]
No [ ]
|
|
|
(3)
|
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
|
|
|
Yes [ ]
No [X]
|
|
|
|
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
|
Pressure
BioSciences, Inc.
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May
16, 2017
|
By:
|
/s/
Richard T. Schumacher
|
|
|
Richard
T. Schumacher
|
|
|
Chief
Executive Officer
|
Pressure Biosciences (QB) (USOTC:PBIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pressure Biosciences (QB) (USOTC:PBIO)
Historical Stock Chart
From Apr 2023 to Apr 2024